Literature DB >> 3075004

Pseudomonas pseudomallei and melioidosis, with special reference to the status in Thailand.

K Kanai1, S Dejsirilert.   

Abstract

Melioidosis is a long-known disease since 1912, but only quite recently we have obtained the knowledges about its actual clinical and epidemiological features. The disease is so unique in having a wide spectrum of disease course and clinical manifestation. The causative agent, P. pseudomallei, is free-living bacterium in the natural environments (soil and surface water) of tropical and subtropical areas. Just like legionnaires' disease, melioidosis is a good example of infectious disease in which pneumonia is produced by inhalation of contaminated soil dusts or water droplets. The infection becomes dormant for years, but with a chance of recrudescence under a variety of insults to the host resistance. The disease, may it be acute or chronic, will be symptomatically confused with malaria, typhoid fever, leptospirosis, septicemia caused by other gram-negative bacteria, tuberculosis and mycotic infections. Isolation of the causative agent from clinical specimens is the only reliable method for diagnosis. Because of the increasing clinical awareness and the development of diagnostic methods, the reported cases of melioidosis have numbered almost one thousand in Thailand during the past 20 years. This country has now the most ample clinical experiences on melioidosis. We have reviewed the history of melioidosis research from bacteriological, immunological, clinical and epidemiological viewpoints, especially including the recent reports in Thailand.

Entities:  

Mesh:

Year:  1988        PMID: 3075004     DOI: 10.7883/yoken1952.41.123

Source DB:  PubMed          Journal:  Jpn J Med Sci Biol        ISSN: 0021-5112


  10 in total

1.  Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics.

Authors:  T Sookpranee; M Sookpranee; M A Mellencamp; L C Preheim
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis.

Authors:  M Sookpranee; P Boonma; W Susaengrat; K Bhuripanyo; S Punyagupta
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  Sudden unexplained death syndrome--a new manifestation in melioidosis?

Authors:  E H Yap; Y C Chan; K T Goh; T C Chao; B H Heng; T W Thong; H C Tan; K T Thong; E Jacob; M Singh
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

Review 4.  Melioidosis: the tip of the iceberg?

Authors:  D A Dance
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

5.  Melioidosis: clinical aspects.

Authors:  Panduka Karunanayake
Journal:  Clin Med (Lond)       Date:  2022-01       Impact factor: 2.659

6.  Burkholderia pseudomallei Requires Zn(sup2+) for Optimal Exoprotease Production in Chemically Defined Media.

Authors:  G Percheron; F Thibault; J Paucod; D Vidal
Journal:  Appl Environ Microbiol       Date:  1995-08       Impact factor: 4.792

7.  In vitro susceptibilities of Pseudomonas pseudomallei to 27 antimicrobial agents.

Authors:  T Yamamoto; P Naigowit; S Dejsirilert; D Chiewsilp; E Kondo; T Yokota; K Kanai
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

8.  Interaction of insulin with Pseudomonas pseudomallei.

Authors:  D E Woods; A L Jones; P J Hill
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Siderophore production by Pseudomonas pseudomallei.

Authors:  H M Yang; W Chaowagul; P A Sokol
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Effectiveness of mosquito magnets for reducing mosquito (Diptera) populations in coastal areas of Samut Songkhram province, Thailand.

Authors:  Tanawat Chaiphongpachara; Sedthapong Laojun; Chaekki Kunphichayadecha
Journal:  J Adv Vet Anim Res       Date:  2018-11-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.